Emami Ltd Q1 FY26 Earnings Results – Revenue Stable, Net Profit Rises 9% YoY

Emami Limited is a leading manufacturer and marketer of personal care and healthcare products, boasting an enviable portfolio of iconic household brands such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm, among others. (Source: 201903 Annual Report Page No: 193)

Q1 FY26 Earnings Summary (Apr–Jun 2025)

• Revenue: ₹904 crore, marginally down 0.22% year-on-year (YoY) from ₹906 crore in Q1 FY25.
• Total Expenses: ₹738 crore, unchanged from ₹738 crore.
• Consolidated Net Profit (PAT): ₹164 crore, up 8.61% from ₹151 crore in the same quarter last year.
• Earnings Per Share (EPS): ₹3.76, up 7.43% from ₹3.50 YoY.

Operational & Strategic Update

• Stable Revenue: The nearly flat revenue reflects steady demand for Emami’s core personal care and healthcare brands amid competitive market conditions.
• Cost Control: Maintaining expenses at the same level as last year demonstrates disciplined cost management despite inflationary pressures.
• Profitability Growth: An 8.6% rise in net profit and a 7.4% increase in EPS highlight improved operational efficiencies and possibly better product mix or pricing strategies.
• Brand Strength: Emami continues to leverage its strong portfolio to sustain consumer loyalty and market penetration, particularly in healthcare and premium personal care segments.
• Market Initiatives: Focus on innovation, digital marketing, and distribution expansion supports long-term brand growth.
• Sustainability and R&D: Investments in sustainable sourcing, product safety, and effectiveness underpin ongoing enhancements to brand equity.

Corporate Developments

Q1 FY26 results underscore Emami’s ability to drive profit growth without revenue expansion, supported by operational efficiencies and brand resilience. The company’s consistent focus on innovation and market adaptation strengthens its competitive edge.

Looking Ahead

Emami Ltd is well-positioned to capitalize on rising consumer awareness and demand for healthcare and personal care essentials. Continued focus on product innovation, market expansion, and cost control is expected to sustain growth and shareholder value through FY26 and beyond.